Latest Asx News

Golden Horse Minerals has initiated a significant diamond drilling campaign at its Hopes Hill gold project, aiming to deepen geological insights and expand high-grade mineralisation zones with government-backed support.

X2M Connect has secured a $3 million deal to supply 100,000 IoT-connected personal safety devices for Seoul’s 2025 Smart City initiative, with potential to scale to one million units.

Rimfire Mining has unveiled compelling high-grade scandium assay results from its Currajong Prospect in NSW’s Fifield District, reinforcing its position as a significant scandium opportunity amid tightening global supply.

Enero Group has replaced its $50 million debt facility with a smaller $15 million revolving credit line from NAB, reflecting a strategic shift towards reduced capital needs and strong cash reserves.

Sunshine Metals has exercised its option early to acquire the Sybil Epithermal Gold Project, setting the stage for drilling to commence in July-August 2025. The project boasts historic high-grade gold results and strategic significance near Charters Towers.

SHAPE Australia reports a robust FY25 with revenue nearing $960 million and a historic project pipeline of $4 billion, signaling strong growth ahead.

Optiscan Imaging Ltd has entered a five-year exclusive collaboration with Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein drug AK-FLOUR®, supporting US clinical trials and FDA regulatory submissions for Optiscan’s InVue® surgical device.

Metcash Limited has announced a fully franked ordinary dividend of AUD 0.095 per share for the fiscal year ending April 2025, accompanied by a Dividend Reinvestment Plan offering.

Kelsian’s US subsidiary Hotard Coaches has landed a major contract to provide workforce transportation for the Louisiana LNG development, marking a significant step in its industrial transport expansion.

Stockland has announced an estimated unfranked dividend of AUD 0.172 per security for the first half of FY25, accompanied by a Dividend Reinvestment Plan offering a 1% discount.

Immutep reports promising Phase I results for IMP761, a novel LAG-3 agonist antibody demonstrating significant T cell inhibition and a clean safety profile, advancing hopes for new autoimmune disease treatments.

Stockland has announced an estimated distribution of 17.2 cents per security for the second half of 2025, maintaining its full-year guidance. The company also offers a 1% discount through its Distribution Reinvestment Plan, encouraging shareholder participation.